Thoracic Oncology

HomeMembersAssemblies and SectionsAssemblies ▶ Thoracic Oncology
Assembly on Thoracic Oncology



ATS / ALA Implementation Guide for Lung Cancer Screening

Welcome Message

Christopher G. Slatore, MD, MS
Christopher G. Slatore, MD, MS
Assembly Chair


Welcome to the Thoracic Oncology Assembly (TOA).  We are committed to improving the lives of all patients with thoracic malignancies.  Our members advance the field through scientific and clinical research that enhance our understanding of the biologic mechanisms that drive cancer, patient-centered clinical initiatives and clinical trials spanning care from early detection through treatment of advanced disease, education of patients and providers, and advocacy.   The Assembly structure promotes interdisciplinary communication, content programming, project development, membership engagement, and collaboration with industry and our sister pulmonary and oncology societies.

Looking ahead to 2023-2024, the TOA Leadership team (see below) encourages our members to participate in the many activities of the assembly.  These include programming of scientific sessions at the annual International Conference, development of projects and documents that advance the science and clinical practice of lung cancer, development of web-based products and tools to educate providers and patients, and providing opportunities within ATS for groups with shared specific interests.  These latter opportunities include the Early Career Professionals Working Group, the Science and Innovation Center, the PhD and Basic & Translational Scientists Working Group, and the newly formed Interventional Pulmonary Advisory Committee. 

Our assembly membership draws from diverse disciplines involved in lung cancer research and clinical care, including pulmonologists, thoracic surgeons, thoracic radiologists, epidemiologists and clinical and basic science researchers.  We are a young and rapidly growing assembly, with membership steadily increasing over the 8 years since the inception of the TOA. ATS prominence in the field of thoracic oncology has increased through TOA efforts, including an increasing presence at the International Conference, lung cancer-focused document production, publications in ATS sponsored journals, and increased visibility through leadership national and international organizations focused on cancer.

We strongly encourage all TOA members to get involved in assembly activities.  Please feel free to contact any of the Leadership team or indicate your interest through the GET INVOLVED! link on our website. 

Warmest Regards,

Christopher G. Slatore, MD, MS


Thoracic Oncology Leadership

Position Person Term
Assembly Chair Christopher G. Slatore, MD, MS 2023-2025
Immediate Past Assembly Chair Patrick Nana-Sinkam, MD 2023-2024
Planning Committee Chair Tobias Peikert, MD 2023-2025
Program Committee Chair Melinda C. Aldrich, PhD, MPH 2023-2024
Program Committee Chair-Elect Catherine Sears, MD, ATSF 2023-2024
Nominating Committee Chair Patrick Nana-Sinkam, MD 2023-2025
Early Career Professionals Working Group Chair Matthew Triplette, MD, MPH 2022-2024
Web Director Tejaswi Nadig, MD 2023-2025
Science and Innovation Center (SIC) Representative Edwin Ostrin, MD, PhD 2022-2024
PhD and Basic & Translational Scientists Working Group Seyed Moghaddam, MD 2022-2024
Interventional Pulmonary Advisory Group Lonny Yarmus, DO, MBA 2020-2022